INSITU BIOLOGICS, INC. HAS REQUESTED THAT THE OMITTED PORTIONS OF THIS DOCUMENT, WHICH ARE INDICATED BY ASTERISKS, BE ACCORDED CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933. INSITU BIOLOGICS, INC. HAS SEPARATELY FILED...License Agreement • July 16th, 2018 • InSitu Biologics, Inc • Pharmaceutical preparations • Minnesota
Contract Type FiledJuly 16th, 2018 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “License Agreement”) is made and entered into as of November 14, 2014 (the “Effective Date”) by and between Lifecore Biomedical, LLC (“Lifecore”) and InSitu Biologics, Inc. (“ISB”).
INSITU BIOLOGICS, INC. HAS REQUESTED THAT THE OMITTED PORTIONS OF THIS DOCUMENT, WHICH ARE INDICATED BY ASTERISKS, BE ACCORDED CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933. INSITU BIOLOGICS, INC. HAS SEPARATELY FILED...License Agreement • June 5th, 2018 • InSitu Biologics, Inc • Pharmaceutical preparations • Minnesota
Contract Type FiledJune 5th, 2018 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “License Agreement”) is made and entered into as of November 14, 2014 (the “Effective Date”) by and between Lifecore Biomedical, LLC (“Lifecore”) and InSitu Biologics, Inc. (“ISB”).